Paclitaxel plus nedaplatin vs. paclitaxel plus carboplatin in women with epithelial ovarian cancer: A multi-center, randomized, open-label, phase III trial

Author:

Li Li1,Zhuang Qingqing2,Cao Zeyi3,Yin Rutie4,Zhu Yaping5,Zhu Lirong6,Xie Xing7,Zhang Youzhong8,Li Li9,Wu Qiang10,Zheng Jianhua11,Zhou Qi12,Li Xiaoping13,Wu Lingying14,Feng Youji5,Wang Changyu15

Affiliation:

1. Department of Gynecology, Cancer Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China

2. Department of Gynecology, The First People's Hospital of Jining, Jining, Shandong 272000, P.R. China

3. Department of Gynecology, The Second Affiliated Hospital of Tsinghua University, Beijing 100049, P.R. China

4. Department of Gynecology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China

5. Department of Gynecology, Shanghai General Hospital, Shanghai 200080, P.R. China

6. Department of Gynecology, Peking University First Hospital, Beijing 100034, P.R. China

7. Department of Gynecology, Women's Hospital School of Medicine Zhejiang University, Hangzhou, Zhejiang 310006, P.R. China

8. Department of Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China

9. Department of Gynecology, Daping Hospital, Research Institute of Surgery Third Military Medical University, Chongqing 400042, P.R. China

10. Department of Gynecology, Jiangsu Cancer Hospital, Nanjing, Jiangsu 210009, P.R. China

11. Department of Gynecology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China

12. Department of Gynecology, Peking University People's Hospital, Beijing 100044, P.R. China

13. Department of Gynecology, Chongqing Cancer Hospital, Chongqing 400030, P.R. China

14. Department of Gynecology, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing 100021, P.R. China

15. Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3